Theravance Biopharma, Inc. (NASDAQ: TBPH) announced the pricing of concurrent underwritten public offerings of 3,850,000 ordinary shares (the "Shares") at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE